Market access for medicines treating rare diseases: Association between specialised processes for orphan medicines and funding recommendations
Author:
Funder
Health Technology Assessment Programme
Publisher
Elsevier BV
Subject
History and Philosophy of Science,Health (social science)
Reference62 articles.
1. Evaluating alignment between Canadian Common Drug Review reimbursement recommendations and provincial drug plan listing decisions: an exploratory study;Allen;CMAJ open,2016
2. Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries;Angelis;Eur. J. Health Econ.,2018
3. The Role of Globalization in Drug Development and Access to Orphan Drugs: Orphan Drug Legislation in the US/EU and in Latin America;Arnold,2015
4. Orphan drugs and their impact on pharmaceutical development;Attwood;Trends Pharmacol. Sci.,2018
5. How to value orphan drugs? A review of European value assessment frameworks;Blonda;Front. Pharmacol.,2021
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. How can health technology assessment be improved to optimise access to medicines? Results from a Delphi study in Europe;The European Journal of Health Economics;2023-11-02
2. Avaliação de tecnologia em saúde para as doenças raras;JMPHC | Journal of Management & Primary Health Care | ISSN 2179-6750;2023-10-03
3. Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?;Value in Health;2023-07
4. Reforming EU and national orphan drug regulations to improve outcomes for patients with rare diseases;BMJ;2023-05-09
5. Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model;Current Medical Research and Opinion;2023-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3